Literature DB >> 9466463

Enhanced expression of metabotropic glutamate receptor 3 messenger RNA in the rat spinal cord during ultraviolet irradiation induced peripheral inflammation.

S J Boxall1, A Berthele, D J Laurie, B Sommer, W Zieglgänsberger, L Urban, T R Tölle.   

Abstract

Metabotropic glutamate receptors are thought to play a role in the development and maintenance of spinal hyperexcitability resulting in hyperalgesia and pain. In this study we have used in situ hybridization to investigate the distribution of metabotropic glutamate receptors mGluR1-7 messenger RNA in the rat spinal cord in a model of inflammatory hyperalgesia. Hyperalgesia was induced in nine-day-old rats by exposure of the left hindpaw to an ultraviolet light source. Lumbar portions of spinal cords were removed from control and ultraviolet-treated animals. In situ hybridization with specific oligonucleotide probes was used to localize metabotropic glutamate receptor messenger RNAs. mGluR1, 3-5 and 7 subtype messenger RNA was detected in the gray matter of the spinal cord with distribution being specific for the different subtypes. A significant increase in the expression of mGluR3 messenger RNA was seen in cells of the dorsal laminae in both sides of the lumbar spinal cord. This increase was most pronounced in laminae II, III and IV but gradually decreased and disappeared by the third day of inflammation. In parallel with this, behavioural experiments revealed mechanical hyperalgesia in both hindlimbs after ultraviolet irradiation. There was no change in mGluR3 messenger RNA expression in the thoracic segments. No changes have been detected in the levels of expression of mGluR 1,2,4,5,7 subtype messenger RNA in spinal cords taken from hyperalgesic animals. These observations show that during ultraviolet irradiation induced inflammation, the synthesis of mGluR3 messenger RNA is altered suggesting that regulation of metabotropic glutamate receptor expression may be instrumental in plastic changes within the spinal cord during the development of hyperalgesia and pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466463     DOI: 10.1016/s0306-4522(97)00246-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

Review 1.  Role of afferent pathways of heat and cold in body temperature regulation.

Authors:  Shigeki Nomoto; Masaaki Shibata; Masami Iriki; Walter Riedel
Journal:  Int J Biometeorol       Date:  2004-07-30       Impact factor: 3.787

2.  Metabotropic glutamate receptors (mGluRs) regulate noxious stimulus-induced glutamate release in the spinal cord dorsal horn of rats with neuropathic and inflammatory pain.

Authors:  Naresh Kumar; Andre Laferriere; Jonathan S C Yu; Tanya Poon; Terence J Coderre
Journal:  J Neurochem       Date:  2010-04-19       Impact factor: 5.372

3.  Metabotropic glutamate and cannabinoid receptor crosstalk in periaqueductal grey pain processing.

Authors:  E Palazzos; V de Novellis; I Marabese; F Rossi; S Maione
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

Review 4.  Glutamate receptors and nociception: implications for the drug treatment of pain.

Authors:  M E Fundytus
Journal:  CNS Drugs       Date:  2001-01       Impact factor: 5.749

5.  The Role of Type 1 Metabotropic Glutamate Receptors in the Generation of Dorsal Root Reflexes Induced by Acute Arthritis or the Spinal Infusion of 4-Aminopyridine in the Anesthetized Rat.

Authors:  Li Ping Zhang; Ying Chen; Barry P Clark; Emanuele Sher; Karin N Westlund
Journal:  J Pain       Date:  2000       Impact factor: 5.820

6.  Interaction of group I mGlu and NMDA receptor agonists within the dorsal horn of the spinal cord of the juvenile rat.

Authors:  K Dang; S Naeem; K Walker; N G Bowery; L Urban
Journal:  Br J Pharmacol       Date:  2002-05       Impact factor: 8.739

7.  Broad spectrum efficacy with LY2969822, an oral prodrug of metabotropic glutamate 2/3 receptor agonist LY2934747, in rodent pain models.

Authors:  Michael P Johnson; Mark A Muhlhauser; Eric S Nisenbaum; Rosa M A Simmons; Beth M Forster; Kelly L Knopp; Lijuan Yang; Denise Morrow; Dominic L Li; Jeffrey D Kennedy; Steven Swanson; James A Monn
Journal:  Br J Pharmacol       Date:  2017-03-13       Impact factor: 8.739

8.  Systemic pre-treatment with a group II mGlu agonist, LY379268, reduces hyperalgesia in vivo.

Authors:  E F Sharpe; A E Kingston; D Lodge; J A Monn; P M Headley
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

9.  Antisense ablation of type I metabotropic glutamate receptor mGluR1 inhibits spinal nociceptive transmission.

Authors:  M R Young; G Blackburn-Munro; T Dickinson; M J Johnson; H Anderson; I Nakalembe; S M Fleetwood-Walker
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

10.  Spinal Metabotropic Glutamate Receptors (mGluRs) are Involved in the Melittin-induced Nociception in Rats.

Authors:  Chul Hyun Cho; Hong Kee Shin
Journal:  Korean J Physiol Pharmacol       Date:  2008-10-31       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.